Investors / Selvedge Venture
Selvedge Venture
Venture capital
Selvedge Venture is a venture capital firm that invests in founders and startups working on age-related medical conditions. It describes its expertise as sitting at the intersection of biotechnology and digital technologies, and it works closely with founders as an active portfolio manager.
Invests inHealthcare & Biotech
In its own wordslife scienceshealthcarebiotechnologymachine learningdataage-related disease
Your fit with Selvedge Venture
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSelvedge Venture lists 12 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 75% of its companies are based in United Kingdom. It invests most often alongside Fifty Years, Ada Ventures and Y Combinator.
No funding round on record names Selvedge Venture yet, so the figures come from its portfolio page.
Round figures show recent activity, not Selvedge Venture's whole history. Rounds on record name 0 companies; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 30th | 12 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers12100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Selvedge Venture head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
12 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Avro Life Science is a clinical stage biotech company that develops topical platform technology for delivering drugs into the skin | Healthcare & Biotech | Portfolio page | ||
| BIOS Health develops neural interfaces and AI to read and write the body's neural data to understand and correct faulty signals in real-time | Healthcare & Biotech | Portfolio page | ||
| Carbometrics is creating a continuous metabolic monitor called i-CAM for various applications. | Healthcare & Biotech | Portfolio page | ||
| CCX provides a secure platform to synchronize global pricing strategy with local execution, facilitate complex deal negotiations and administer innovative contracts. | Healthcare & Biotech | Portfolio page | ||
| Exogene develops next-generation immune-activating medicines against solid tumors using a lab-in-the-loop AI platform. | Healthcare & Biotech | Portfolio page | ||
| Kytopen develops scalable genome engineering platforms to solve cell therapy manufacturing problems at the discovery stage. | Healthcare & Biotech | Portfolio page | ||
| Mesh Bio empowers healthcare with real-time insights to predict chronic diseases trajectories, optimise clinical workflows, and guide patients toward better outcomes. | Healthcare & Biotech | Portfolio page | ||
| MultiOmic Health develops precision medicines for age-related chronic multifactorial diseases | Healthcare & Biotech | Portfolio page | ||
| Ochre Bio develops novel medicines for liver disease using human data and AI models | Healthcare & Biotech | Portfolio page | ||
| Oxford Medical Products has developed a proprietary gastroretentive hydrogel platform for weight management and drug delivery | Healthcare & Biotech | Portfolio page | ||
| Sanome helps clinical teams understand their patients better and detect deterioration earlier using a certified AI-powered Clinical Decision Support tool. | Healthcare & Biotech | Portfolio page | ||
| Yuri develops research hardware and mission solutions that enable scientists and life-science companies to investigate biology under altered-gravity conditions. | Healthcare & Biotech | Portfolio page |
About this data
site last read 13 Nov 2026- Site
- selvedgeventure.com
- Last read
- 13 Nov 2026
- Watching since
- 7 Nov 2026
- Companies checked
- 12
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Selvedge Venture's profile as data
Pull Selvedge Venture's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/selvedgeventure.com
# also
GET /v1/firms/selvedgeventure.com/portfolio
GET /v1/firms/selvedgeventure.com/coinvestors
GET /v1/firms/selvedgeventure.com/news